SCHEMBL29801726

SCHEMBL29801726

COc1cc2ncnc(O)c2cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 7/20 0.53
▸ RET P07949 12/20 0.50
▸ KDR P35968 9/20 0.50
▸ KIF5B P33176 9/20 0.50
▸ JAK3 P52333 3/20 0.46
▸ RIPK2 O43353 2/20 0.46
▸ GAK O14976 1/20 0.46
▸ STK10 O94804 1/20 0.46
▸ FLT3 P36888 1/20 0.46
▸ AAK1 Q2M2I8 1/20 0.46
▸ Q6ZSR9 Q6ZSR9 1/20 0.46
▸ SLK Q9H2G2 1/20 0.46
▸ IRAK4 Q9NWZ3 1/20 0.46
▸ RPS6KA6 Q9UK32 1/20 0.46
▸ ALK Q9UM73 1/20 0.46
▸ LCK P06239 1/20 0.44
▸ ABCB1 P08183 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ NOD1 Q9Y239 1/20 0.44
▸ ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216888 1.00 EGFR (0.53) EGFRRETKDRKIF5BJAK3
Hydrochloric Acid SCHEMBL28006468 0.98 EGFR (0.52) EGFRRETKDRKIF5BJAK3
SCHEMBL7802744 0.93 EGFR (0.53) EGFRRETKDRKIF5BJAK3
SCHEMBL2476964 0.89 RET (0.55) EGFRRETKDRKIF5BJAK3
Piperidine SCHEMBL4197120 0.87 EGFR (0.44) EGFRRETKDRKIF5BJAK3
SCHEMBL12447316 0.84 EGFR (0.52) EGFRRETKDRKIF5BJAK3
SCHEMBL20813476 0.84 EGFR (0.52) EGFRRETKDRKIF5BJAK3
SCHEMBL16016669 0.84 RET (0.47) EGFRRETKDRKIF5BJAK3
SCHEMBL10945990 0.83 EGFR (0.52) EGFRRETKDRKIF5BJAK3
SCHEMBL8230611 0.83 EGFR (0.51) EGFRRETKDRKIF5BJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110590683-B Preparation method of intermediate of targeting drug AZD3759 山东四环药业股份有限公司 2022-08-19 — — CN claimed
CN-110590683-B Preparation method of intermediate of targeting drug AZD3759 山东四环药业股份有限公司 2022-08-19 — — CN disclosed
CN-110590683-B Preparation method of intermediate of targeting drug AZD3759 山东四环药业股份有限公司 2022-08-19 — — CN disclosed
CN-113307797-B Polysubstituted quinazoline compound and application thereof 江南大学 2022-08-09 — — CN disclosed
Send feedback